A detailed history of Jane Street Group, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 257,534 shares of AKRO stock, worth $7.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
257,534
Previous 250,075 2.98%
Holding current value
$7.65 Million
Previous $6.32 Million 4.35%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.31 - $24.62 $136,574 - $183,640
7,459 Added 2.98%
257,534 $6.04 Million
Q1 2024

May 15, 2024

SELL
$17.76 - $31.18 $97,218 - $170,679
-5,474 Reduced 2.14%
250,075 $6.32 Million
Q4 2023

Feb 14, 2024

BUY
$11.38 - $50.33 $904,857 - $4 Million
79,513 Added 45.17%
255,549 $5.97 Million
Q3 2023

Nov 14, 2023

SELL
$41.19 - $52.25 $3.64 Million - $4.62 Million
-88,390 Reduced 33.43%
176,036 $8.9 Million
Q2 2023

Aug 14, 2023

BUY
$36.89 - $56.88 $7.52 Million - $11.6 Million
203,790 Added 336.09%
264,426 $12.3 Million
Q1 2023

May 15, 2023

BUY
$37.27 - $50.24 $987,505 - $1.33 Million
26,496 Added 77.61%
60,636 $2.32 Million
Q4 2022

Feb 14, 2023

BUY
$33.44 - $54.8 $877,331 - $1.44 Million
26,236 Added 331.93%
34,140 $1.87 Million
Q3 2022

Nov 14, 2022

SELL
$10.15 - $34.05 $29,698 - $99,630
-2,926 Reduced 27.02%
7,904 $269,000
Q2 2022

Aug 16, 2022

SELL
$8.0 - $15.01 $126,576 - $237,488
-15,822 Reduced 59.37%
10,830 $102,000
Q1 2022

May 17, 2022

SELL
$12.97 - $22.26 $43,799 - $75,172
-3,377 Reduced 11.25%
26,652 $378,000
Q4 2021

Feb 15, 2022

BUY
$19.87 - $26.24 $119,140 - $157,335
5,996 Added 24.95%
30,029 $635,000
Q3 2021

Nov 16, 2021

BUY
$18.65 - $25.46 $286,333 - $390,887
15,353 Added 176.88%
24,033 $538,000
Q2 2021

Aug 16, 2021

SELL
$24.81 - $32.35 $57,162 - $74,534
-2,304 Reduced 20.98%
8,680 $216,000
Q1 2021

May 18, 2021

BUY
$24.04 - $34.19 $264,055 - $375,542
10,984 New
10,984 $319,000

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.38B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.